Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma from the phase 2 PRIMO trial: Results of an interim analysis Meeting Abstract
| Authors: | Brammer, J. E.; Zinzani, P. L.; Zain, J.; Mead, M.; Casulo, C.; Jacobsen, E. D.; Gritti, G.; Litwak, D.; Cohan, D.; Katz, D. J.; Mehta-Shah, N.; Pro, B.; Horwitz, S. M. |
| Abstract Title: | Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma from the phase 2 PRIMO trial: Results of an interim analysis |
| Meeting Title: | 63nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413901186 |
| DOI: | 10.1182/blood-2021-148939 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2456 -- Hybrid meeting, also took place online -- Source: Wos |
